These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8212269)

  • 21. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific inhibition of heart allograft rejection by serum from liver-grafted rats.
    Kamada N; Shinomiya T; Tamaki T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):570-1. PubMed ID: 3274823
    [No Abstract]   [Full Text] [Related]  

  • 23. Different response of intestinal and cardiac allografts to pretreatment with UV-B irradiated donor-specific leukocytes (DL) or DL alone.
    Gundlach M; Oluwole SF; Pohland CC; Broelsch CE; Hardy MA
    Transplant Proc; 1996 Oct; 28(5):2482-3. PubMed ID: 8907913
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
    Ito H; Hamano K; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolonged heart allograft survival following postoperative blood transfusion.
    Marushack MM; Snider GR; Muka-Ives M; Nelson EW; Maxwell JG; Shelby J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1420-1. PubMed ID: 3274343
    [No Abstract]   [Full Text] [Related]  

  • 27. Digital image analysis of major histocompatibility complex class I and class II expression during site-specific immune suppression with topical cyclosporine.
    Tatem L; Hou A; Black KS; Llull R; Hewitt CW
    Transplant Proc; 1995 Feb; 27(1):344-5. PubMed ID: 7879022
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplant Proc; 1989 Jun; 21(3):3555. PubMed ID: 2662527
    [No Abstract]   [Full Text] [Related]  

  • 29. Tolerance to experimental cardiac allografts but not xenografts is induced after simultaneous neonatal intrathymic inoculation with allo and xenogeneic cells.
    Shen Z; Mohiuddin M; Goldstein C; Yokoyama H; DiSesa VJ
    Transplant Proc; 1996 Apr; 28(2):719-20. PubMed ID: 8623363
    [No Abstract]   [Full Text] [Related]  

  • 30. Depletion of donor class II MHC positive passenger cells and reduction of immunogenicity in longstanding rat heart allografts.
    Klempnauer J; Steiniger B
    Transplant Proc; 1989 Feb; 21(1 Pt 1):487. PubMed ID: 2650182
    [No Abstract]   [Full Text] [Related]  

  • 31. Donor-specific transfusion: critical role of class I antigen presenting molecules in rat liver transplantation.
    Yokoi Y; Yamaguchi A; Kimura H; Nakamura S; Baba S; Amemiya H
    Transplant Proc; 1995 Apr; 27(2):1558-9. PubMed ID: 7725409
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine.
    Gyopar AF; Loertscher R; Guttman RD; Tchervenkov JI
    Transplantation; 1993 May; 55(5):1199-202. PubMed ID: 8497904
    [No Abstract]   [Full Text] [Related]  

  • 33. Donor-soluble histocompatibility antigen selectively potentiates suppressor elements while decreasing the frequency of alloantigen-specific T cytotoxic cells.
    Stepkowski SM; Ghobrial R; Wang B; Ito Y; Goto S; Hamashima T; Kahan BD
    Transplant Proc; 1993 Oct; 25(5):2875. PubMed ID: 8212270
    [No Abstract]   [Full Text] [Related]  

  • 34. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of modulation of donor class II antigen expression on the survival of rat cardiac allografts.
    Barron PT; Tyerman K; McLeish M; Thiru S; Collier SJ
    Transplant Proc; 1990 Aug; 22(4):1931-2. PubMed ID: 2117818
    [No Abstract]   [Full Text] [Related]  

  • 36. Examination of the clonal deletion hypothesis following transfusions in rat cardiac transplants.
    Takiff H; Novak M; Yin L; Iwaki Y; Terasaki PI
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1452-4. PubMed ID: 3274352
    [No Abstract]   [Full Text] [Related]  

  • 37. Intrathymic spleen cell inoculation and ALS fails to induce tolerance to rat pancreas allografts.
    Schulak JA; Mulligan DC; Robinson A
    Transplant Proc; 1997; 29(1-2):1070-1. PubMed ID: 9123203
    [No Abstract]   [Full Text] [Related]  

  • 38. Donor-specific tolerance to cardiac, but not renal, allografts is induced by intrathymic transfer of donor splenocytes.
    Nakafusa Y; Goss JA; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):292-4. PubMed ID: 8438305
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.
    Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of perioperative portal venous administration of donor lymphocytes on survival of rat cardiac allografts and renal grafts of the mongrel dog.
    Hirakawa K; Yoshimura N; Lee CJ; Yasui H; Ohsaka Y; Hamashima T; Oka T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):346-7. PubMed ID: 8438328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.